State Street
ELOX

State Street’s Eloxx Pharmaceuticals, Inc. Common Stock ELOX Stock Holding History

State Street’s Portfolio ELOX Stock Details ELOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-4,749
Closed -$32K – 4948
2022
Q3 		$32K Hold
4,749
– – ﹤0.01% 4755
2022
Q2 		$51K Hold
4,749
– – ﹤0.01% 4722
2022
Q1 		$106K Buy
4,749
+199
+4% +$3.92K ﹤0.01% 4623
2021
Q4 		$127K Sell
4,550
-310
-6% -$13.5K ﹤0.01% 4521
2021
Q3 		$317K Buy
4,860
+130
+3% +$8.02K ﹤0.01% 4168
2021
Q2 		$377K Sell
4,730
-6,213
-57% -$518K ﹤0.01% 3966
2021
Q1 		$1.45M Sell
10,943
-264
-2% -$40.4K ﹤0.01% 3543
2020
Q4 		$1.78M Buy
11,207
+74
+0.7% +$9.04K ﹤0.01% 3410
2020
Q3 		$1.17M Buy
11,133
+299
+3% +$35.8K ﹤0.01% 3396
2020
Q2 		$1.31M Buy
10,834
+300
+3% +$34K ﹤0.01% 3338
2020
Q1 		$826K Buy
10,534
+41
+0.4% +$6.67K ﹤0.01% 3350
2019
Q4 		$3.09M Buy
10,493
+956
+10% +$193K ﹤0.01% 3074
2019
Q3 		$1.72M Buy
9,537
+50
+0.5% +$14.2K ﹤0.01% 3266
2019
Q2 		$3.78M Buy
9,487
+470
+5% +$198K ﹤0.01% 2970
2019
Q1 		$4.21M Buy
9,017
+359
+4% +$174K ﹤0.01% 2826
2018
Q4 		$4.16M Buy
8,658
+62
+0.7% +$34.2K ﹤0.01% 2806
2018
Q3 		$5.86M Buy
8,596
+379
+5% +$243K ﹤0.01% 2783
2018
Q2 		$5.61M Buy
+8,217
New +$5.33M ﹤0.01% 2804

Other funds holding ELOX

MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AFG
American Financial Group Cincinnati, Ohio $270M AUM 3.25% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
AS
Altshuler Shaham Tel Aviv, Israel $5.54B AUM 44.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

State Street's ELOX Position: Q4 2022 in Review

State Street sold out of Eloxx Pharmaceuticals, Inc. Common Stock (ELOX) in Q4 2022, closing a stake of 4,749 shares — an estimated $32K sold.

State Street first reported a position in ELOX in Q2 2018 and held it in 18 quarters. The position peaked at $5.86M in Q3 2018. 19 funds tracked by Wall St. Rank hold ELOX as of Q4 2022.

  • State Street reported no remaining Eloxx Pharmaceuticals, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • State Street sold 4,749 Eloxx Pharmaceuticals, Inc. Common Stock shares in Q4 2022, an estimated $32K.
  • State Street first reported a position in Eloxx Pharmaceuticals, Inc. Common Stock in Q2 2018 and held it in 18 quarters.
  • State Street's Eloxx Pharmaceuticals, Inc. Common Stock position peaked at $5.86M in Q3 2018.
  • 19 funds tracked by Wall St. Rank held Eloxx Pharmaceuticals, Inc. Common Stock as of Q4 2022.

Based on State Street's 13F filing for Q4 2022, filed 14 Feb 2023.